Get started
Markets India Stocks Health Technology Pharmaceuticals: Other

MOREPEN LABORATORIES LTD MOREPENLAB

MOREPENLAB BSE
MOREPENLAB
MOREPEN LABORATORIES LTD BSE
See more on advanced chartSee more on advanced chart
 
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
See more on advanced chartSee more on advanced chart
Overview
News Ideas Financials Technicals

MOREPENLAB Stock Chart

Get $150 worth of Bitcoin from TradeStation Crypto with a new account. Start trading

Ideas

Videos only
likely to break the bullish flag
MOREPENLAB
, 1D
Long
MOREPENLAB: likely to break the bullish flag

T- 65/90 Sl- 56 chart is self-explanatory, check it out.

MSFT LONG
MOREPENLAB
, 1D
Long
MOREPENLAB: MSFT LONG

CUP AND HANDLE PATTERN ABOUT TO BREAKOUT

Morepen will give more gain!
MOREPENLAB
, 120
Long
MOREPENLAB: Morepen will give more gain!

NSE:MOREPENLAB has completed its corrective structure and given a breakout which it will retest and then wont look back in few days to come. NSE:CNXPHARMA is gaining pace and hence most of the Pharma stocks. A new rally is in motion!

MOREPEN LAB CHANNEL BREAKOUT
MOREPENLAB
, 1D
Long
MOREPENLAB: MOREPEN LAB CHANNEL BREAKOUT

#CHANNEL BREAKOUT #HEALTHCARE TECH SECTOR # BEST STOCK FOR LONG TERM INVESTMENT

Morepenlab - Penny Stock!
MOREPENLAB
, W
Long
MOREPENLAB: Morepenlab - Penny Stock!

Monthly chart of Morepen laboratories shows price action is forming cup and handle pattern. Weekly chart shows the price is breaking the triangle. One can buy morepen above 20 for the targets 28, 33 and 39. Consult your financial manager before investing.

Buy with SL 17.5 for Tgt 40.
MOREPENLAB
, M
Long
MOREPENLAB: Buy with SL 17.5 for Tgt 40.

Retest of RSI & Price support zone usually offers very comfortable entry opportunity with awesome R:R for medium to long term investors

Technicals

Financials

Valuation
Enterprise Value/EBITDA, TTM —
Enterprise Value, FQ —
Market Cap — Basic —
Number of Employees —
Number of Shareholders —
Price/Earnings, TTM —
Price/Revenue, TTM —
Price/Book Ratio, FY —
Price/Sales Ratio, FY —
Balance Sheet
Current Ratio, FQ —
Debt to Equity, FQ —
Net Debt, FQ —
Quick Ratio, FQ —
Total Assets, FQ —
Total Debt, FQ —
Operating Metrics
Return on Assets, TTM —
Return on Equity, TTM —
Return on Invested Capital, TTM —
Revenue per Employee, TTM —
Price History
Average Volume (10 day) —
Beta - 1 Year —
Price - 52 Week High —
Price - 52 Week Low —
Dividends
Dividends Paid, FY —
Dividends per Share, FY —
Expected Annual Dividends —
Dividends Yield —
Margins
Net Margin, TTM —
Gross Margin, TTM —
Operating Margin, TTM —
Pretax Margin, TTM —
Income Statement
Basic EPS, Net Income —
Earnings per Share, Basic, TTM —
EBITDA, TTM —
Gross Profit, FY —
Last Annual EPS —
Last Annual Revenue, FY —
Net Income, FY —
Total Revenue, FY —
Free Cash Flow, TTM —
More financials

Profile

Sector: Health Technology
Industry: Pharmaceuticals: Other
Morepen Laboratories Ltd. engages in the manufacture and market of bulk drugs and pharmaceutical formulations. It operates through the following business segments: Global Generics, Finished Formulations, Home Health, and Dr. Morepen. The company was founded by K.B. Suri on December 1, 1984 and is headquartered in New Delhi, India.

Breaking news

More news